Previous close | 60.08 |
Open | 60.42 |
Bid | 43.70 x 800 |
Ask | 66.71 x 800 |
Day's range | 59.35 - 63.33 |
52-week range | 33.59 - 63.33 |
Volume | |
Avg. volume | 439,583 |
Market cap | 2.371B |
Beta (5Y monthly) | 0.92 |
PE ratio (TTM) | 23.70 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | 30 Nov 2016 |
1y target est | N/A |
CHICAGO, May 02, 2024--Adtalem reported Q3 FY24 results reflecting robust operating performance through accelerated total enrollment growth and enhanced profitability.
CHICAGO, April 22, 2024--Adtalem to release its third quarter fiscal 2024 results on May 2, after financial markets close, followed by a conference call at 5:00 p.m. ET.
CHICAGO, March 25, 2024--Over 800 Adtalem medical school students and grads are set to join alumni resident ranks, ready to tackle U.S. healthcare needs.